Werewolf Therapeutics Inc
NASDAQ:HOWL

Watchlist Manager
Werewolf Therapeutics Inc Logo
Werewolf Therapeutics Inc
NASDAQ:HOWL
Watchlist
Price: 0.6604 USD 5.04% Market Closed
Market Cap: 32.1m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of HOWL.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HOWL Intrinsic Value
Not Available
Base Case Scenario
Compare HOWL to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HOWL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Werewolf Therapeutics Inc

Current Assets 68.2m
Cash & Short-Term Investments 65.7m
Other Current Assets 2.5m
Non-Current Assets 11.5m
PP&E 10.5m
Other Non-Current Assets 944k
Current Liabilities 17.6m
Accounts Payable 1.1m
Accrued Liabilities 10.5m
Other Current Liabilities 6m
Non-Current Liabilities 32.4m
Long-Term Debt 21.7m
Other Non-Current Liabilities 10.8m
Efficiency

Free Cash Flow Analysis
Werewolf Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Werewolf Therapeutics Inc

Revenue
0 USD
Operating Expenses
-71.6m USD
Operating Income
-71.6m USD
Other Expenses
-1.2m USD
Net Income
-72.8m USD
Fundamental Scores

HOWL Profitability Score
Profitability Due Diligence

Werewolf Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
Declining ROE
hidden
Profitability
Score

Werewolf Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

HOWL Solvency Score
Solvency Due Diligence

Werewolf Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
hidden
Solvency
Score

Werewolf Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HOWL Price Targets Summary
Werewolf Therapeutics Inc

Wall Street analysts forecast HOWL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HOWL is 6.29 USD with a low forecast of 3.03 USD and a high forecast of 10.5 USD.

Lowest
Price Target
3.03 USD
359% Upside
Average
Price Target
6.29 USD
852% Upside
Highest
Price Target
10.5 USD
1 490% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Werewolf Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HOWL is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

HOWL Insider Trading
Buy and sell transactions by insiders